Literature DB >> 7920426

DNA strand-breaking activities of quinolone antimicrobial agents under visible light irradiation.

Y Iwamoto1, A Kurita, T Shimizu, T Masuzawa, K Uno, M Yagi, T Kitagawa, T Oku, Y Yanagihara.   

Abstract

The DNA strand-breaking activities of 9 quinolones, widely used as antimicrobial agents and suspected to induce photo-dermatological disorders in humans, were examined under irradiation using standard domestic fluorescent lamps. Two quinolones, tosufloxacin and enoxacin, converted the supercoiled covalently closed circular plasmid DNA to the open circular form under visible light irradiation. The maximum of photodynamic single strand-breaking activity for tosufloxacin was found to be 12% at 50 microM and that of enoxacin was 33% at a concentration of 2 mM. The DNA strand-breaking activities of photoirradiated tosufloxacin and enoxacin were markedly inhibited by NaN3 but only partially by D-mannitol, superoxide dismutase (SOD) and catalase did not inhibit these activities. These results suggest that some quinolone antimicrobial agents can be activated by visible light and induce phototoxic DNA damage in various organisms. We should carefully investigate such phototoxic activities during the development of new quinolones to avoid producing phototoxic disorders in man.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7920426     DOI: 10.1248/bpb.17.654

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Sparfloxacin phototoxicity: potential photoaugmentation by ultraviolet A and B sources.

Authors:  Y Tokura; Y Iwamoto; K Mizutani; M Takigawa
Journal:  Arch Dermatol Res       Date:  1996       Impact factor: 3.017

2.  New findings on the structure-phototoxicity relationship and photostability of fluoroquinolones with various substituents at position 1.

Authors:  Norihiro Hayashi; Yoshihiro Nakata; Akira Yazaki
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.